| Dr Hetvi Kiritkumar Joshi, MD | |
|
130 W Ravine Rd, Kingsport, TN 37660-3837 | |
| (423) 224-3628 | |
| (423) 230-8502 |
| Full Name | Dr Hetvi Kiritkumar Joshi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 130 W Ravine Rd, Kingsport, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023340510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 50228 (Tennessee) | Secondary |
| 208M00000X | Hospitalist | 50228 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Roseville | Roseville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
According to a new case report patients receiving radioactive isotopes should be warned that they may trigger radiation alarms for several weeks after the treatment has been completed.
The Hill: On Monday, experts warned during a Capitol Hill discussion hosted by the Congressional Health Care Caucus that "the absence of mandatory clinical trials for biosimilar drugs could compromise their safety and effectiveness." The recently passed health reform law "outlined a pathway for the Food and Drug Administration (FDA) to approve next-generation biopharmaceuticals modeled on original breakthrough drugs.
Investing in the health of expectant mothers is crucial in helping to create a healthier nation, according to a health expert at Sheffield Hallam University.
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
› Verified 4 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
According to a new case report patients receiving radioactive isotopes should be warned that they may trigger radiation alarms for several weeks after the treatment has been completed.
The Hill: On Monday, experts warned during a Capitol Hill discussion hosted by the Congressional Health Care Caucus that "the absence of mandatory clinical trials for biosimilar drugs could compromise their safety and effectiveness." The recently passed health reform law "outlined a pathway for the Food and Drug Administration (FDA) to approve next-generation biopharmaceuticals modeled on original breakthrough drugs.
Investing in the health of expectant mothers is crucial in helping to create a healthier nation, according to a health expert at Sheffield Hallam University.
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hetvi Kiritkumar Joshi, MD 105 W Stone Dr Ste 6a, Kingsport, TN 37660-3256 Ph: (423) 408-7220 | Dr Hetvi Kiritkumar Joshi, MD 130 W Ravine Rd, Kingsport, TN 37660-3837 Ph: (423) 224-3628 |
News Archive
According to a new case report patients receiving radioactive isotopes should be warned that they may trigger radiation alarms for several weeks after the treatment has been completed.
The Hill: On Monday, experts warned during a Capitol Hill discussion hosted by the Congressional Health Care Caucus that "the absence of mandatory clinical trials for biosimilar drugs could compromise their safety and effectiveness." The recently passed health reform law "outlined a pathway for the Food and Drug Administration (FDA) to approve next-generation biopharmaceuticals modeled on original breakthrough drugs.
Investing in the health of expectant mothers is crucial in helping to create a healthier nation, according to a health expert at Sheffield Hallam University.
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
› Verified 4 days ago
Patrina Nicolyn Cradic, FNP-C Hospitalist Medicare: Medicare Enrolled Practice Location: 130 W Ravine Rd, Kingsport, TN 37660 Phone: 423-224-4000 | |
Jessica Machue, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 102 E Ravine Rd, Kingsport, TN 37660 Phone: 423-245-9600 | |
Mr. Naveed H Memon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 W Ravine Rd, Kingsport, TN 37660 Phone: 423-224-3628 Fax: 423-230-8502 | |
Jamie Kendall Bartley, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Brookside Dr, 3rd Floor, Kingsport, TN 37660 Phone: 423-857-5905 Fax: 423-857-5904 | |
Dr. Dennis Starr, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 W Ravine Rd, Kingsport, TN 37660 Phone: 423-282-1480 Fax: 423-928-1353 | |
Dr. Mircea Boiciuc, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2033 Meadowview Ln, Ste 200, Kingsport, TN 37660 Phone: 423-857-2793 Fax: 423-578-8025 | |
Dr. Vitaly Nazarov, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 W Ravine Rd, Kingsport, TN 37660 Phone: 423-224-3628 Fax: 423-230-8502 |